ArticleOncology letters2025
Methionine-MAT2A-SAM axis controls lipid levels by regulating ACSL4.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Methionine-Mitochondria Axis in Cancer: Metabolic Cross-Talk and Therapeutic Vulnerabilities.Current pharmacology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The four major metabolic pathways in cells, including amino acid, glucose, nucleotide and lipid metabolism, constitute the fundamental framework of cellular metabolic networks. However, the intricate reciprocal regulatory mechanisms between amino acid metabolism and lipid metabolism remain poorly understood. In the present study, an essential amino acid-deficient culture medium was established and applied to cell cultures. Subsequent analysis using flow cytometry demonstrated that methionine deprivation significantly reduced cellular lipid accumulation and impaired the fatty acid uptake capacity. Mechanistic investigations using western blotting revealed that the methionine-methionine adenosyltransferase 2A (MAT2A)-S-adenosylmethionine (SAM) metabolic axis regulates the protein expression of ACSL4, a critical enzyme governing fatty acid uptake. Notably, the results indicated that the protein expression of MAT2A may be tightly regulated by SAM through a feedback mechanism, ensuring homeostasis of the methionine-MAT2A-SAM metabolic axis. In summary, the findings of the present study demonstrate that the methionine-MAT2A-SAM axis modulates lipid metabolism by regulating ACSL4 expression and function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.